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Abstract The objective of this study is to assess whether ultrasmall superpara-
magnetic iron oxide (USPIO)-induced changes of the water proton longitudinal
relaxation rate (R1) provide a means to assess blood hemodynamics of tumors. Two
types of murine colon tumors (C26a and C38) were investigated prior to and fol-
lowing administration of USPIO blood-pool contrast agent with fast R1 measure-
ments. In a subpopulation of mice, R1 was measured following administration of
hydralazine, a well-known blood hemodynamic modiﬁer. USPIO-induced R1
increase in C38 tumors (DR1 = 0.072 ± 0.0081 s
-1) was signiﬁcantly larger than
in C26a tumors (DR1 = 0.032 ± 0.0018 s
-1, N = 9, t test, P\0.001). This was in
agreement with the immunohistochemical data that showed higher values of relative
vascular area (RVA) in C38 tumors than in C26a tumors (RVA = 0.059 ± 0.015
vs. 0.020 ± 0.011; P\0.05). Following administration of hydralazine, a decrease
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Magnetic Resonancein R1 value was observed. This was consistent with the vasoconstriction induced by
the steal effect mechanism. In conclusion, R1 changes induced by USPIO are sen-
sitive to tumor vascular morphology and to blood hemodynamics. Thus, R1 mea-
surements following USPIO administration can give novel insight into the effects of
blood hemodynamic modiﬁers, non-invasively and with a high temporal resolution.
1 Introduction
It is well established that tumor vasculature plays a key role in tumor growth [1].
Tumor vessels are not only morphologically, but also physiologically distinct from
host vessels [2]. Knowledge about these aspects of tumor vasculature is critical to
tumor therapy, both in novel anti-angiogenesis therapeutic treatments and in
conventional cytotoxic therapy. Moreover, in recent studies, blood hemodynamic
modiﬁers have been employed to enhance the effects of treatment [3]. However, the
exact mechanism by which blood hemodynamic modiﬁers act is still not well
understood [4] and their effects on tumor hemodynamics remain unclear [5]. It is
crucial, therefore, to characterize the tumor vasculature and its response to blood
hemodynamic modiﬁers in order to assess and improve the effectiveness of current
therapeutic treatments.
Magnetic resonance imaging (MRI), in combination with contrast agent
administration, has proven useful in the characterization of tumor vasculature.
Several studies have shown that magnetic susceptibility effects, caused by blood-
pool contrast agents that consist of ultrasmall superparamagnetic particles of iron
oxide (USPIO), can be used to assess blood volume and vessel sizes within tumors.
USPIOs have been mostly employed in combination with quantitative and/or
qualitative T2 and T2* measurements [6–12]. In particular, the enhancement in the
transverse relaxation rates R2 (=1/T2) and R2* (=1/T2*), after administration of
USPIO, provides an index proportional to the blood volume of the microvasculature
and macrovasculature, respectively. However, quantitative DR2 and DR2* mea-
surements are characterized by relatively long acquisition times, due to the long
repetition time TR needed to minimize T1 effects.
Quantitative T1 MRI, in combination with USPIO administration, represents an
alternative approach to T2/T2* USPIO contrast-enhanced MRI, in particular, when
fast assessment (i.e., on the order of seconds) of blood hemodynamics is needed.
In this study, detailed measurements of changes in longitudinal relaxation rate R1
(=1/T1), following USPIO administration were performed within in vivo tumor
tissue. R1 was measured with the inversion–recovery snapshot fast low-angle
shot (IR-FLASH) imaging sequence pre- and post-USPIO administration, in two
different types of murine colon carcinoma (C26a, C38). The ﬁndings were
compared with the vascularity of these tumor types as determined by immunohis-
tochemistry. To assess whether USPIO-induced R1 changes provide a means to
assess blood hemodynamics with high temporal resolution, we administered
hydralazine—a central vasodilator which induces vasoconstriction in subcutaneous
tumors by the steal effect mechanism [13]—and monitored R1 changes in time.
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1232 Materials and Methods
2.1 MRI
All procedures were approved by the Radboud University Nijmegen Medical Center
Animal Care and Use Committee. C26a (n = 9) and C38 (n = 9) murine colon
tumor tissue fragments were implanted subcutaneously in female Balb/C and C57/
Bl6 mice, respectively, of 8–12 weeks of age. Experiments were performed when
tumors reached the diameter of approximately 0.8 cm. Mice were anesthetized with
isoﬂurane inhalation (1.5–2%); in each mouse, a catheter was inserted in the tail
vein for the administration of the contrast agent and the tumor was positioned in the
center of a 10-mm diameter surface radio-frequency (RF) coil used as a transmitter/
receiver. During the measurements, the body temperature was monitored with a
rectal ﬂuoroptic probe (Luxtron 712, Luxtron Corporation, California, USA) and
maintained at a constant temperature of 37 ± 1C with a warm water pad.
MRI experiments were performed on a 7T/200 mm horizontal-bore MR spec-
trometer interfaced to a SMIS console and equipped with a gradient insert with a
gradientstrengthof150 mT/mandrisetimeof150 ls.Theimageacquisitionprotocol
started with three-gradient echo scout images followed by multislice gradient echo
images for anatomical localization of the tumor. Imaging parameters were: repetition
time(TR) = 400 ms,echotime(TE) = 10 ms,imagematrixsizeof128 9 128,ﬁeld
ofview(FOV)of5.8 cm 9 5.8 cm, slicethickness(SLT)of0.7 mmand1excitation
per phase-encoding step. IR-FLASH imaging [14, 15] was then performed on a slice
through the center of the tumor, prior to and following administration of an USPIO
blood-pool contrast agent (Sinerem
, Guerbet, France; 150 lmol Fe/kg). Imaging
parameters were: TR/TE = 5 ms/2.7 ms, image matrix size of 64 9 64, FOV of
3c m9 3 cm,SLTof1.6 mm.Inthissequence,thelongitudinalmagnetizationisﬁrst
invertedbyahyperbolicsecantadiabaticinversionpulseandthenrepeatedlysampled
byatrainofsmallﬂip-angle(5)read-outGaussianpulsestogeneratemultipleimages
at different time points on the T1 water proton recovery curve. Digitized RF spoiling
pulses with phase angle increments of 117 [16], and a gradient spoiling were applied
inordertospoilthetransversesteady-statemagnetizationpriortoeachread-outpulse.
The time interval between the inversion pulse and the ﬁrst image was 52 ms. Ten
dummyscanswereappliedpriortoeachimageacquisitionsothatthetotalacquisition
time per image was 370 ms. The lines in the k-space were acquired with a centric
proﬁle order to generate 16 images, which sampled the recovery of the longitudinal
magnetization over ca. 5 s, at intervals of 370 ms.
To assess the precision of the R1 measurement, in order to determine whether the
changes in R1 induced by the contrast agent are greater than the measurement error, four
repeated R1 measurements were performed prior to and following administration of
U S P I Oo nag r o u po fm i c e( n = 5, C26a tumors and n = 5, C38 tumors). Further, in a
group of mice with C38 tumors (n = 3), an intraperitoneal catheter was inserted for
hydralazine injection. Hydralazine was dissolved in NaCl 0.9% to a concentration of
0.33 mg/ml and intraperitoneally injected at a dose of 2.5 mg/kg of mouse weight. The
MRI protocol was as before with the only difference that after the post-USPIO R1
measurement, hydralazine was injected, and the R1value was measured 5 min thereafter.
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1232.2 Data Analysis
The Levenberg–Marquardt non-linear least squares algorithm was used to analyze
the R1 relaxation data. R1 maps were obtained from the entire set of 16 images.
Voxel-by-voxel R1 maps, pre- and post-USPIO, and after hydralazine, were
generated from a three-parameter ﬁt of the image intensities according to the
equation: S(TI) = A ? B exp(-TI/T1*) and the value of the corrected R1 was
calculated from the formula: R1 = (T1*(B/A - 1))
-1 which is valid in the small
ﬂip-angle limit. Pixel-by-pixel T1 maps were calculated using an algorithm
described elsewhere [17]. First, for each pixel, the signal intensity of the 16
magnitude images was evaluated and the minimum value (Smin) was determined.
Second, an inversion–recovery curve (i.e., with negative and positive values) was
generated by inverting all the data on the left of the minimum value Smin. The ﬁt was
determined, as well as the coefﬁcient of determination (R
2), which is a measure of
the goodness of the ﬁt. Third, the same procedure was repeated choosing one point
on the left (Smin-1) and one point on the right (Smin?1)o fSmin, so that two additional
inversion–recovery curves were generated by inverting all the data on the left of
(Smin-1) and of (Smin?1), respectively. The ﬁt was determined, as well as R
2. Thus,
in total, three inversion–recovery curves were generated. The inversion–recovery
which displayed the best ﬁt (i.e., highest R
2) was chosen for calculating the T1
relaxation time. The ﬁtting algorithm is further described in Ref. [17]. From the
voxel-by-voxel R1 maps, DR1 maps (DR1 = R1post - R1pre, where R1post and R1pre
are the R1 post- and pre-USPIO, respectively) were calculated. For each tumor, the
mean DR1 was then calculated by drawing a region-of-interest (ROI)—which
included the tumor core—on the DR1 map and averaging the DR1 values of all
voxels within the ROI.
To assess the precision of the measured R1 values, we performed four repeated
measurements of R1 prior to and following administration of USPIO. For each
tumor, four R1 maps pre-USPIO and four R1 maps post-USPIO were generated as
described in the previous paragraph. From each R1 map, the mean R1 was calculated
by averaging the R1 values of all voxels within an ROI which included the tumor
core. The standard deviation (SD) over four repeated R1 measurements, pre-USPIO
and post-USPIO was calculated [18]. All data are expressed as mean ± SD. The
Levenberg–Marquardt non-linear least squares algorithms were implemented in
MatLab (Mathworks, Natick, MA, USA).
In order to compare the changes in the R1 relaxation time (DR1) in the C26a
tumor with the DR1 value in the C38 tumor line, the data were further analyzed with
the software package Prism (GraphPad Software Inc., CA, USA). The statistical
signiﬁcance (P\0.001) of differences between the DR1 value in the C26a and C38
tumors was determined by means of a two-tailed Student’s t test.
2.3 Theory
SincetheUSPIOremainsintravascular,modelingoftheeffectsoftheUSPIOontheR1
relaxation rate requires the framework of a two-compartmentexchange model, where
the two compartments are the intra- and extravascular space. The relaxation behavior
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123ofthetwo-compartmentexchangemodeldependsontheexchangerates
-1,deﬁnedas
the sum of s1
i and s1
e , where si and se are the water proton lifetimes in the intra- and
extravascular compartment, respectively, and on the absolute value of the difference
betweenthewaterprotonrelaxationratesoftheintra-andextravascularspace(R1iand
R1e, respectively). The precise value of s
-1 is not exactly known [19]; however, the
reported values are ca. 1 Hz [20–23]. The two-compartment model is in slow
exchange when the condition s
-1  |R1i - R1e| is satisﬁed. Schwarzbauer et al. [24]
showedthat,followingcontrastagentadministration,inthecaseofslowexchangethe
observed change in relaxation rate DR1 is equal to PS/(k - RBV), where PS is the
permeability-surfaceareaproductforwateracrossbloodvesselwalls,kisthetissue-to-
blood partition coefﬁcient and RBV is the regionalblood volume. For typicalvalues of
k and RBV [24], RBV  k and therefore, after Taylor series expansion (1/[1 - x] *
[1 ? x], for |x|  1), DR1 * (PS/k)(1 ? RBV/k).
2.4 Immunohistochemistry
In two separate groups of mice (n = 6 for C38 and n = 5 for C26a) with tumors of
approximately the same size as used for the MR experiments, tumor vascularity was
determined by immunohistochemistry. After the animals were killed by cervical
dislocation, their tumors were excised immediately and stored under liquid nitrogen.
Frozen tumor sections of 5 lm thickness were cut for staining and further analysis
of vasculature. After thawing, the sections were ﬁxed in cold (4C) acetone for
10 min. Between all consecutive steps of the staining procedure, sections were
rinsed three times for 2 min in phosphate buffered saline. Sections were mounted in
Fluorostab (Organon, Boxtel, The Netherlands). Endothelial structures were stained
with 9F1, which is a rat monoclonal antibody to mouse endothelium (Department of
Pathology, University Medical Centre Nijmegen, The Netherlands) [25]. Then
sections were incubated for 30 min at 37C with goat anti-rat-Alexa546 (Molecular
Probes, Leiden, The Netherlands) and diluted 1:200 in polyclonal liquid diluent
(Euro-DPC, Breda, The Netherlands). Quantitative data for tumor vascularity were
acquired by a semiautomatic method based on a computerized digital image
analysis system, as described previously [26, 27]. Whole tumor sections were
scanned for 9F1 positive structures and a contour line was drawn to delineate the
tumor area thereby excluding non-tumor tissue from the analyses. Consecutive
hematoxylin and eosin-stained tumor sections were employed to distinguish
parenchyma from non-tumor tissue. The resulting composite image was divided
into smaller ROIs (230 9 230 lm). In each ROI the relative vascular area (RVA:
9F1 positive area divided by the viable tumor area) was calculated. From this, a new
image map was created in which the voxels had values of the RVA values in the
corresponding ROIs.
3 Results
The IR-FLASH provided a fast method for measuring the water proton R1 relaxation
rate in murine colon carcinoma. Figure 1 shows the sixteen IR-FLASH images of a
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123central slice through a C26a murine colon carcinoma. The acquisition time for the
whole set of images was ca. 5 s. The combination of RF and gradient spoiling
implemented in the IR-FLASH measurements provided images virtually free from
artifacts. The signal intensity of the last image (image 16) was typically less than
the signal intensity of the ﬁrst image, due to small saturating effect originating from
the read-out pulses. At the inversion time of approximately 1,000 ms, the
longitudinal magnetization goes through the null point. The signal intensity changes
from a single voxel within the tumor, as well as the ﬁt of the signal recovery to a
monoexponential function are illustrated in Fig. 1 (right). The R
2 value of 0.9996
indicates the excellent agreement between data points and ﬁt.
To estimate the precision of the measured R1 values of each tumor, four repeated
measurements were performed prior to and following USPIO administration
(Fig. 2). The column graph shows the values of R1 obtained from the four repeated
measurements prior to and following administration of USPIO, in a C26a and a C38
tumor. The horizontal line indicates the mean of the four measurements, while each
point represents the value of one measurement. Prior to USPIO administration,
R1 = 0.5467 ± 0.0024 s
-1 in the C26a and R1 = 0.5791 ± 0.0029 s
-1 in the C38.
Following USPIO administration, R1 = 0.5692 ± 0.0013 s
-1 in the C26a and
R1 = 0.6596 ± 0.0030 s
-1 in the C38. As a result, in both tumors, the USPIO-
induced change DR1 was greater than the SD value. The repeated measurements
were performed in ten tumors. The results of the data analysis for all tumors are
given in Table 1. The SD pre- and post-USPIO administration was typically ca. 1–3
10
-3 s
-1. A small increase in SD in the post-USPIO measurements was observed.
On the other hand, changes in R1 induced by USPIO (third row in Table 1) were
well above SD values in all cases.
In Fig. 3, a column graph of the changes in the R1 relaxation rate following
USPIO administration in all tumors showed a clear difference between C38 and
C26a tumors. The R1 increase in the C38 tumors (DR1 = 0.072 ± 0.0081 s
-1) was
signiﬁcantly larger than in the C26a tumors (DR1 = 0.032 ± 0.0018 s
-1,
Fig. 1 IR-FLASH measurements of the R1 relaxation rate in a C26a murine colon carcinoma. The
sixteen IR-FLASH images of a C26a murine colon carcinoma (left). Plot of signal amplitudes from a
single voxel within the tumor (right). The dashed line indicates the monoexponential ﬁt (R
2 = 0.9996)
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123P\0.001). Among the C26a tumors, changes in R1 were very similar, while
the C38 tumors displayed a broader range of changes in R1. It should be noted that
the smallest DR1 observed in the C38 group was greater than the largest DR1 of the
C26a group.
The immunohistochemically determined RVA of the C38 tumors was larger than
the RVA of the C26a tumors (0.059 ± 0.015 vs. 0.020 ± 0.011; P = 0.0013). This
is illustrated in Fig. 4, which shows an RVA map, as well as the vascular structure,
of a typical C38 and C26a tumor. The photomicrograph clearly shows the
substantial difference in vascular volume and morphology between the C26a and
C38 tumors.
Figure 5 shows the R1 relaxation rate before USPIO administration and changes
in the R1 relaxation rate after USPIO and hydralazine administration. The increase
in R1 after USPIO administration was then followed by a decrease in R1, after
hydralazine administration.
Fig. 2 ColumngraphofthechangesintheR1relaxationratefollowingUSPIOadministrationinaC26aand
aC38coloncarcinoma.SymbolsindicatethevaluesofR1fromfourrepeatedmeasurementsperformedprior
to and following USPIO administration. Prior to USPIO administration, in the example shown here,
R1 = 0.5467 ± 0.0024 s
-1 in the C26a and R1 = 0.5791 ± 0.0029 s
-1 in the C38. Following USPIO
administration,R1 = 0.5692 ± 0.0013 s
-1intheC26aandR1 = 0.6596 ± 0.0030 s
-1in theC38.Inboth
tumors, the post-USPIO R1 is signiﬁcantly higher than pre-USPIO R1
Table 1 SD of R1 calculated from four repeated measurements, performed in ten tumors and the change
in R1 induced by the USPIO
#1
(C38)
#2
(C38)
#3
(C38)
#4
(C38)
#5
(C38)
#6
(C26a)
#7
(C26a)
#8
(C26a)
#9
(C26a)
#10
(C26a)
SDPre-USPIO
([10
3 s]
-1)
1.2 2.9 0.6 2.5 1.1 1.5 2.4 1.0 0.9 1.3
SDPost-USPIO
([10
3 s]
-1)
1.9 3.1 1.7 2.7 1.2 3.4 1.3 1.8 1.2 1.1
DR1([10
3 s]
-1) 84.1 99.8 45.1 72.2 59.5 33.7 23.1 27.9 30.4 26.3
The SD value provides an estimate of the precision of the in vivo measured values of R1 in tumors, with
the experimental setup employed in the current study. In the last row, the change in R1 induced by the
USPIO. In all cases, the SD value is well below the change in R1 induced by the contrast agent
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123Fig. 3 Column graph of the changes in water proton R1 relaxation rate (DR1) following USPIO
administration in the C26a and C38 colon carcinoma. The R1 increase in the C38 (DR1 =
0.072 ± 0.0081 s
-1) was signiﬁcantly larger than in the C26a colon carcinoma (DR1 = 0.032 ±
0.0018 s
-1, P\0.001). The DR1 in all C38 colon carcinoma was larger than 0.045 s
-1 (dotted line),
while the DR1 in all C26a colon carcinoma was smaller than this value
Fig. 4 RVA maps of the C26a (a) and C38 (b) tumor section. Each pixel represents a 0.23 9 0.23 mm
ROI. Maps are scaled to 100% which corresponds to an RVA value of 21%. c and d Detailed
photomicrographs of the tumors in a and b, showing the typical vascular structure of the C26a (c) and the
C38 (d) colon carcinoma
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1234 Discussion
In the current study, we propose a method which uses fast R1 measurements on
tumors prior to and following USPIO administration in order to monitor the tumor
hemodynamics. While USPIO-induced changes in the transverse relaxation rates R2
and R2* within tumors have been experimentally investigated in a number of
studies, less attention has been paid to quantitative measurements of R1 changes
[28]. Here, we ﬁrst performed detailed measurements of R1, to assess the precision
of our experimental setup, in order to evaluate the signiﬁcance of the R1 changes.
The high signal-to-noise ratio, achieved by (i) the use of a small surface coil, (ii) the
positioning of the imaged slice in the plane of the coil itself and (iii) the high ﬁeld
strength, results in a reliable and precise measure of R1. As a consequence, R1
changes following USPIO are signiﬁcantly larger than the experimental error
associated with the R1 measurement.
The USPIO-induced increase in R1 may be attributed to the exchange of water
protons between the intra- and extravascular space [19]. Following administration of
USPIO, R1 of the intravascular water protons in blood signiﬁcantly increases (i.e.,
T1 decreases from a value of ca. 2 s to a value below 200 ms [28]), whereas the
extravascular water protons affected by the contrast agent are only those which are
in exchange with the intravascular space. As a result, following USPIO adminis-
tration, the value of |R1i - R1e| increases to a value of ca. 5 Hz, which is greater
than the suggested values of s (*1H z[ 20–23]). Thus, USPIO administration drives
the system towards slow exchange. In the limit of slow exchange, two decaying
components are expected. However, since only about 5% of the water signal can be
attributed to intravascular water protons and since the T1 relaxation time of the
intravascular component is very short, MRI using the inversion–recovery imaging
Fig. 5 Graph of normalized R1 prior to USPIO administration (ﬁrst time point), following USPIO
administration (second time point) and 5 min after hydralazine administration (third time point) in three
C38 colon carcinomas. Following hydralazine administration, R1 decreased in all tumors, indicating a
vasoconstriction effect
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123sequences cannot resolve the two decaying components, that is, it cannot detect the
fast-decaying component. The measured T1 is therefore representative of the
extravascular component. In the case of slow exchange, as pointed out in Sect. 2,
DR1 is proportional to the blood volume and to the PS product. Therefore,
differences in DR1 between various tumor lines may be due to differences in blood
volume, PS product or both. In our study, there was a statistically signiﬁcant
difference (P\0.001) between DR1 in the C26a and C38 colon carcinoma, with
DR1 being larger in the C38 than in the C26a colon carcinoma. This result indicates
a difference in tumor vascular morphology between the two tumor lines, which is
attributed either to differences in the PS product or in blood volume. The results
from the immunohistochemistry, which was performed in the current study on the
same tumor lines, indicate that there was a difference in RVA between the two
tumor lines, with the C38 colon carcinoma exhibiting a higher RVA.
More relevant and of immediate interpretation are the R1 changes for
investigating hemodynamic effects in tumors. In fact, in case of vasoconstriction
or vasodilation within the same tumor, DR1 can be strictly related to vasoconstric-
tion or vasodilation effects. In other words, if—as a response to a blood
hemodynamic modiﬁer—vasoconstriction (or vasodilation) occurs within the tumor,
there will be a decrease (or increase) of both surface area and blood volume.
Therefore, any vasoconstriction (or vasodilation) is reﬂected in a decrease (or
increase) of R1. The decrease in R1 after hydralazine administration, which is a well-
known central vasodilator, suggested a hydralazine-induced vasoconstriction in
tumors. This is in line with the observation of vasoconstriction by the steal effect
mechanism [29] due to hydralazine reported in other studies of subcutaneous tumors
utilizing ﬂuorescent staining [30] and contrast-enhanced MRI [31]. The ‘paradox-
ical’ vasoconstrictor effect (the ‘steal effect’) in tumor vasculature, as a result of
administration of vasodilator agents, such as hydralazine for instance [29–31], can
be explained in the following way: the systemic vasodilation of all ‘healthy’ blood
vessels in the body takes away blood (‘‘steal’’ the blood) from the tumor
vasculature. In fact, since the tumor vasculature itself does not respond directly to
the vasoactive agent, as it has a minimal capability of blood ﬂow autoregulation
[13], a reduction in tumor blood ﬂow/volume is observed. Tumors have developed a
number of ways to ensure a proper blood supply, such as incorporation of pre-
existent vessels (also referred to as vessel co-option), vessel modulation (e.g.,
dilatation and intussusception) and angiogenesis [1, 8]. The ability to monitor tumor
blood volume with a high temporal resolution in vivo will provide essential insight
into tumor physiology and is a prerequisite to evaluate tumor response to therapy. It
will further improve our knowledge of a tumor vasculature response to vasoactive
agents (such as in serial measurements of CO2/O2 breathing experiments, for
instance), tumor capability for blood ﬂow autoregulation, and transient hemody-
namic effects in tumors.
The most signiﬁcant advantage of quantitative R1 over quantitative R2*/R2
measurements is the temporal resolution: a few seconds for R1 measurements versus
minutes in R2 measurements. It should be noted that a temporal resolution of
seconds could be also achieved with T2*/T2-weighted imaging; on the other hand,
measurement of relative changes in the signal intensity makes interindividual
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123comparison less reliable. With respect to fast quantitative T2*/T2 measurements,
based on a steady-state free precession type of acquisition [32], for instance, they
suffer from B1 inhomogeneties and artifacts due to off-resonance (B0 inhomoge-
neities), in particular, at high ﬁelds. Quantitative R1 measurements could be an
interesting alternative to T2*/T2-weighted images and quantitative R2*/R2 measure-
ments in assessing changes in blood hemodynamics and thus can give novel insight
into the effects of blood hemodynamic modiﬁers on tumor vasculature, non-
invasively and with a high temporal resolution.
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